Crohn's Disease, FDA
IBD drug market rattles as Lilly’s Omvoh nabs FDA approval for second IL-23p19 in Crohn’s
The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the second interleukin-23p19 specific inhibitor approved for both major types of inflammatory bowel disease,
Hosted on MSN8h
Scientists Make Groundbreaking Discovery in the Search for the Cause of Inflammatory Bowel DiseaseIn a major breakthrough, researchers in the UK have discovered a potential root cause of inflammatory bowel disease (IBD), a ...
According to new research, wearables like an Apple Watch or an Oura smart ring can detect the symptoms and predict flare-ups ...
SARS-CoV-2 infection, especially a severe case or without vaccination, significantly increases the long-term risk for developing autoimmune and autoinflammatory connective tissue diseases ...
Wearable devices can identify, differentiate, and predict flare-ups, or the worsening of symptoms and inflammation, in ...
AbbVie executives said they have high hopes for Skyrizi and Rinvoq in the inflammatory bowel disease market after Humira ...
UK scientists have made a major breakthrough while investigating inflammatory bowel disease, which could change the lives of ...
A new storage technique can keep protein-based drugs and vaccines stable without keeping them cold, potentially eliminating ...
Wearable devices can identify, differentiate, and predict flare-ups, or the worsening of symptoms and inflammation, in inflammatory bowel disease (IBD), Mount Sinai researchers have shown in a ...
Love Is Blind alum Kwame Appiah has had a difficult last couple of months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback